Options Data for US Stocks: End-of-Day and Historical Learn more

ProKidney Corp. icon

ProKidney Corp. (PROK NASDAQ) stock market data APIs

$1.0422 -0.01(-1%)
as of November 16, 2026
Try our APIs with free plan!

ProKidney Corp. Financial Data Overview

Price chart is built with Anychart

ProKidney Corp., a clinical-stage biotechnology company, engages in the development of cell therapies for the treatment of chronic kidney diseases in the United States. The company develops rilparencel, a cell therapy with autologous selected renal cells, which is in Phase III clinical trial for the treatment of advanced chronic kidney disease and type 2 diabetes. It is also involved in the development of cryopreserved versions of rilparencel, including REGEN-006 and REGEN-008 which are both in Phase III clinical trials; REGEN-002, REGEN-003, and REGEN-007 which are in Phase II clinical trials; and REGEN-004 which is Phase I clinical trial. The company was founded in 2015 and is headquartered in Winston-Salem, North Carolina.

Prev. Close 1.0422
Open 1.0349
High 1.1098
Low 1.0057
52 wk Range 0.8702-2.65
Market Cap 417 M
Shares Outstanding 209 M
Revenue 775 K
EPS -0.17
Beta 1.894

* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.


ETFs with ProKidney Corp. (top by weight)

Ticker
100-day Price Change
Weight
SURI.US Simplify Propel Opportunities ETF
-1.99 (-11.24%)
0.72
BBC.US Virtus LifeSci Biotech Clinical Trials ETF
-11.67 (-22.22%)
0.50
IWC.US iShares Micro-Cap ETF
-29.65 (-14.93%)
0.03
VTWG.US Vanguard Russell 2000 Growth Index Fund ETF Shares
-34.03 (-11.97%)
0.01
VRTGX.US Vanguard Russell 2000 Growth Index Fund Institutional Shares
-54.6 (-10.08%)
0.01
VTWO.US Vanguard Russell 2000 Index Fund ETF Shares
-11.18 (-9.21%)
0.01
VRTIX.US Vanguard Russell 2000 Index Fund Institutional Shares
-35.87 (-7.72%)
0.01
IWO.US iShares Russell 2000 Growth ETF
-46.68 (-11.98%)
0.01

* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.


Why to choose EODHD?

Prices start at $19.99

24/7 Live support

Robust, powerful and reliable data

API Simplicity of a few lines of code


Try our APIs
with free plan!

Or get access to advanced financial data starting only $19.99

TRY NOW

Get ProKidney Corp. data using free add-ons & libraries


Get ProKidney Corp. Fundamental Data

ProKidney Corp. logo

ProKidney Corp. Fundamental data includes:

  • Net Revenue: 775 K
  • EBITDA: -185 907 008
  • Earnings Per Share: 0
  • Income Statements
  • Balance Sheets
  • Cash flows

Plans with Fundamental data

Starting from

$ 59.99 /mo.
COMPARE PLANS

End-of-day & Earnings data

Get ProKidney Corp. Earnings data

Corporate Events Calendar & News package for

$ 19.99 /mo.

What’s included:

  • Latest Release: 2026-11-12
  • EPS/Forecast: -0.13
GET THE PACKAGE

Get ProKidney Corp. End-of-day data

EOD Historical Data package for

$ 19.99 /mo.

What’s included:

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends
GET THE PACKAGE

ProKidney Corp. News

Get ProKidney Corp. fresh news feed via Financial News API

Corporate Events Calendar & News package for

$19.99/mo.

Try our APIs
with free plan!

Or get access to advanced financial data starting only $19.99

TRY NOW
  • Flexibility: No long-term commitments, just a minimum of one month
  • Instant access: Get your API key and instructions within seconds of subscribing
Best Offer
All-In-One
$99.99/mo.

What’s included:

  • API Calls per Day: 100 000/day
  • API Requests per Min.: 1000/minute
  • Type of Usage: Personal use

Data access:

Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.

GET THE PACKAGE

Send the request

Leave your email and our team will contact you ASAP.